Medical Articles

Onasemnogene abeparvovec-brve

Recombinant AAV9 capsid containing SMN1 gene (Gene therapy for spinal muscular atrophy)

Description

One-time intravenous gene therapy for spinal muscular atrophy (SMA). Delivers functional SMN1 gene to motor neurons to address genetic root cause of disease.

Mechanism of action

AAV9 viral vector carrying SMN1 transgene crosses blood-brain barrier and transduces motor neurons, producing functional survival motor neuron (SMN) protein to restore motor neuron survival and function.

This page is restricted. Please Login / Register to view this page.

Mechanism of action

AAV9 viral vector carrying SMN1 transgene crosses blood-brain barrier and transduces motor neurons, producing functional survival motor neuron (SMN) protein to restore motor neuron survival and function.

This page is restricted. Please Login / Register to view this page.